Bank of New York Mellon Corp Sells 21,842 Shares of Humana Inc. (NYSE:HUM)

Bank of New York Mellon Corp reduced its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 3.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 715,657 shares of the insurance provider's stock after selling 21,842 shares during the period. Bank of New York Mellon Corp owned about 0.59% of Humana worth $189,363,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of HUM. LFA Lugano Financial Advisors SA grew its position in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new position in shares of Humana in the fourth quarter worth approximately $33,000. Riverview Trust Co bought a new position in shares of Humana in the first quarter worth approximately $34,000. Garde Capital Inc. bought a new position in shares of Humana in the first quarter worth approximately $36,000. Finally, Transce3nd LLC bought a new position in shares of Humana in the fourth quarter worth approximately $38,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HUM. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 target price on the stock in a report on Thursday, May 1st. Oppenheimer raised their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday, May 1st. Robert W. Baird raised their target price on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Bank of America cut their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a report on Tuesday, June 17th. Finally, Guggenheim assumed coverage on shares of Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price target on the stock. Sixteen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $280.76.

Humana Stock Performance

Shares of Humana stock opened at $237.00 on Tuesday. The stock has a market cap of $28.60 billion, a price-to-earnings ratio of 16.76, a PEG ratio of 1.81 and a beta of 0.44. The firm's 50-day moving average is $239.76 and its 200 day moving average is $258.95. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The company had revenue of $32.11 billion for the quarter, compared to analysts' expectations of $32 billion. During the same quarter in the previous year, the business posted $7.23 EPS. Humana's revenue was up 8.4% compared to the same quarter last year. Sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.